- Home
- Advocacy
- Latest News and Practice Data
- FDA COVID-19 EUA Policies Will Remain After Public Health Emergency Ends in May
The Food and Drug Administration (FDA) recently announced that the COVID-19 Emergency Use Authorization (EUA) policies would remain in effect after the COVID-19 Public Health Emergency declaration ends mid-April. The Director of the FDA Office of In Vitro Diagnostics and Radiological Health, Timothy Stenzel, MD, PhD, FCAP, announced that the FDA has an independent authority to end EUAs under the public health emergency.
On January 30, President Biden announced that the COVID-19 public health emergency will end on May 11. By extending the emergency, states and Medicaid services will continue with affiliated waivers for various sectors of the US health care system until May 11.
The CAP will provide additional information as it becomes available.